# Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke

Study · id `cardio:ct-nct04734548` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04734548](<https://clinicaltrials.gov/study/NCT04734548>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04734548

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

## Technical summary

Registry record NCT04734548. Randomized; quadruple masking; primary purpose treatment. Start 2020-10-28 (actual); primary completion 2022-07-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 151 participants (enrolled count; ClinicalTrials.gov record NCT04734548, source copy `cardio:ctgov-nct04734548-2022-10-21`, retrieved 2026-10-26)
- Started: 2020-10-28 (actual) (ClinicalTrials.gov record NCT04734548, source copy `cardio:ctgov-nct04734548-2022-10-21`, retrieved 2026-10-26)
- Primary completion: 2022-07-25 (actual) (ClinicalTrials.gov record NCT04734548, source copy `cardio:ctgov-nct04734548-2022-10-21`, retrieved 2026-10-26)
- Completion: 2022-09-07 (actual) (ClinicalTrials.gov record NCT04734548, source copy `cardio:ctgov-nct04734548-2022-10-21`, retrieved 2026-10-26)
- Countries: France; Germany; Spain (ClinicalTrials.gov record NCT04734548, source copy `cardio:ctgov-nct04734548-2022-10-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04734548-2022-10-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
- Condition: Stroke
- Condition: Acute Stroke
- Condition: Ischemic Stroke
- Intervention (Drug): ApTOLL
- Intervention (Other): Placebo
- Lead sponsor: aptaTargets S.L.
- Lead sponsor class: INDUSTRY
- Collaborator: Ministry of Science and Innovation, Spain
- Collaborator class: OTHER\_GOV
- Collaborator: Anagram
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial (`cardio:pubmed-37338893`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 407cc6a5c83200a62b7412d733e12ab96c733910a5f2830ef54b07b70d07e5b8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
